AZTR
HEALTHCAREAzitra Inc
$0.25-0.00 (-0.45%)PRE
Live · AMEX · May 9, Close
AI Insight
What's Moving AZTR Today?
No stock-specific AI insight has been generated for AZTR yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.10$2.40
$0.25
Fundamentals
Market Cap$4M
P/E Ratio—
EPS$-2.25
Dividend Yield—
Dividend / Share—
ROE-2.3%
Profit Margin—
Debt / Equity—
Trading
Volume462K
Avg Volume (10D)—
Shares Outstanding16.2M
AZTR News
20 articles- Azitra, Inc. Announces New U.S. Patent Protecting ATR-12 ProgramYahoo Finance·May 6, 2026
- Azitra, Inc. Announces Poster Presentation at ASGCT 2026 Highlighting ATR-01 Program for Ichthyosis VulgarisYahoo Finance·Apr 28, 2026
- Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million with up to an Additional Approximately $20.9 MillionYahoo Finance·Mar 19, 2026
- Azitra Receives Notice of Non-Compliance from NYSE American and Makes NYSE American Section 610(b) Public AnnouncementYahoo Finance·Mar 13, 2026
- Azitra, Inc. Announces Cancellation of 2026 Special Meeting of StockholdersYahoo Finance·Mar 5, 2026
- AZTR: New Site for ATR-04 TrialYahoo Finance·Mar 4, 2026
- Azitra, Inc. Announces Full Year 2025 Results and Provides Business UpdatesYahoo Finance·Feb 27, 2026
- Azitra, Inc. Announces Addition of MD Anderson Cancer Center as Clinical Site for Phase 1/2 Trial of ATR-04 Targeting EGFRi-Associated Skin RashYahoo Finance·Feb 24, 2026
- Azitra, Inc. to Present at BIO Investment & Growth SummitYahoo Finance·Feb 19, 2026
- Azitra Announces Adjournment of Special Meeting and Information for Reconvened Special MeetingYahoo Finance·Feb 6, 2026
- Azitra, Inc. to Present at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare ConferenceYahoo Finance·Jan 7, 2026
- Azitra Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE AmericanYahoo Finance·Dec 17, 2025
- Azitra, Inc. Announces Pricing of $1.5 Million Private Placement Priced At a Premium To Market Under NYSE RulesYahoo Finance·Nov 24, 2025
- AZTR: ATR-01 Data PresentedYahoo Finance·Nov 18, 2025
- Azitra, Inc. Announces Q3 2025 Results and Provides Business UpdatesYahoo Finance·Nov 12, 2025
- Azitra, Inc. Addresses False Report Regarding Sale of SecuritiesYahoo Finance·Nov 7, 2025
- Wall Street Set to Open Higher Monday as Investors Look Ahead to a Week of Earnings ReportsYahoo Finance·Oct 20, 2025
- Azitra, Inc. Announces Positive Preclinical Data for ATR-01 Program, Designed to Treat Ichthyosis VulgarisYahoo Finance·Oct 20, 2025
- Azitra to Participate in Dermatologic Rare Disease Panel at Maxim Growth SummitYahoo Finance·Oct 15, 2025
- Azitra Receives Notice of Non-Compliance from NYSE AmericanYahoo Finance·Oct 3, 2025
All 20 articles loaded
Price Data
Open$0.26
Previous Close$0.25
Day High$0.26
Day Low$0.23
52 Week High$2.40
52 Week Low$0.10
52-Week Range
$0.10$2.40
$0.25
Fundamentals
Market Cap$4M
P/E Ratio—
EPS$-2.25
Dividend Yield—
Dividend / Share—
ROE-2.3%
Profit Margin—
Debt / Equity—
Trading
Volume462K
Avg Volume (10D)—
Shares Outstanding16.2M
About Azitra Inc
Azitra Inc, a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. The company is headquartered in Branford, Connecticut.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeAMEX
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—